Molecular pharmacology of glucocorticoids: recent advances and future perspectives

References

• Oshima H. Mechanisms of the molecular action of glucocorti-coids. Jpn J Ftheumatol 1997;7:1–11.
   Google Scholar
• Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev 1984;5:25–44.
   Google Scholar
• Cahill G. Action of adrenal cortical steroids on carbohydrate metabolism. In: Christy NP, editor. Human adrenal cortex. New York: Harper & Row; 1973. p. 205–39.
   Google Scholar
• Maitra US, Khan MS, Rosner W. Corticosteroid-binding globulin receptor of the rat hepatic membrane: solubilization, partial char-acterization, and the effect of steroids on binding. Endocrinology 1993;133:1817–22.
   Google Scholar
• Nakhla AM, Khan MS, Rosner W. Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding globulin. Biochem Biophys Res Commun 1988;153:1012–8.
   Google Scholar
• Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, et al. Targeted disruption of the glucocorticoid recep-tor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608–21.
   PubMed Web of Science ®Google Scholar
• Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998;93:531–41.
   PubMed Web of Science ®Google Scholar
• Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000;289:2344–7.
   PubMed Web of Science ®Google Scholar
• Graham BS, Tucker WS Jr. Opportunistic infections in endog-enous Cushing's syndrome. Ann Intern Med 1984;101:334–8.
   PubMed Web of Science ®Google Scholar
• Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851–7.
   Google Scholar
• Evans RM. The steroid and thyroid hormone receptor super-family. Science 1988;240:889–95.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835–9.
   PubMed Web of Science ®Google Scholar
• Nuclear Receptor Nomenclature Committee. A unified nomen-clature system for the nuclear receptor superfamily. Cell 1999;97: 161–3.
   PubMed Web of Science ®Google Scholar
• Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318:635–41.
   PubMed Web of Science ®Google Scholar
• Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor p, a potential endogenous inhibitor of glucocorticoid action in humans. J Chin Invest 1995;95:2435–41.
   PubMed Web of Science ®Google Scholar
• de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, et al. The non-ligand binding p-isoform of the human glucocorti-coid receptor (hGRp): tissue levels, mechanism of action, and potential physiologic role. Mol Med 1996;2:597–607.
   PubMedGoogle Scholar
• Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor p isoform. Expression, biochemical properties, and puta-tive function. J Biol Chem 1996;271:9550–9.
   Google Scholar
• Oakley RH, Webster JC, Sar M, Parker CR Jr, Cidlowski JA. Expression and subcellular distribution of the p-isoform of the human glucocorticoid receptor. Endocrinology 1997;138:5028–38.
   Google Scholar
• Otto C, Reichardt HM, Schutz G. Absence of glucocorticoid receptor-p in mice. J Biol Chem 1997;272:26665–8.
   PubMedGoogle Scholar
• Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J-A, Brönnegard M, Wikstrom AC. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologi-cally significant repressor. J Biol Chem 1997;272:26659–64.
   PubMedGoogle Scholar
• Bamberger CM, Else T, Bamberger AM, Beil FU, Schulte HM. Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor. Mol Cell Endocrinol 1997;136: 23–8.
   Google Scholar
• Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor I. J Exp Med 1997;186: 1567–74.
   PubMed Web of Science ®Google Scholar
• de Lange P, Koper JW, Huizenga NA, Brinkmann AO, de Jong FH, Karl M, et al. Differential hormone-dependent transcrip-tional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 1997;11:1156–64.
   PubMed Web of Science ®Google Scholar
• Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, et al. Increased glucocorticoid receptor p in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999;159(5 Pt 1):1600–4.
   Google Scholar
• Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA, et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 1999;254:559–65.
   PubMed Web of Science ®Google Scholar
• Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphory-lation by mitogen-activated protein kinase. Science 1995;270: 1491–4.
   PubMed Web of Science ®Google Scholar
• Bunone G, Briand PA, Miksicek RJ, Picar D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15:2174–83.
   PubMed Web of Science ®Google Scholar
• Joel PB, Traish AM, Lannigan DA. Estradiol-induced phospho-rylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 1998;273: 13317–23.
   Google Scholar
• Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA. pp90rskl regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol Cell Biol 1998;18:1978–84.
   PubMed Web of Science ®Google Scholar
• Tremblay A, Tremblay GB, Labrie F, Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor a through phosphorylation of activation function AF-1. Mol Cell 1999;3:513–9.
   PubMed Web of Science ®Google Scholar
• Rogatsky I, Waase CL, Garabedian MJ. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differ-ences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem 1998;273: 14315–21.
   Google Scholar
• Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999;97:17–27.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J 2001;20:1341–52.
   PubMedGoogle Scholar
• Rachez C, Suldan Z, Ward J, Chang CP, Burakov D, Erdjument-Bromage H, et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev 1998;12: 1787–800.
   Google Scholar
• Severne Y, Wieland S, Schaffner W, Rusconi S. Metal binding "finger" structures in the glucocorticoid receptor defined by site-directed mutagenesis. EMBO J 1988;7:2503–8.
   PubMedGoogle Scholar
• Scheidereit C, Westphal HM, Carlson C, Bosshard H, Beato M. Molecular model of the interaction between the glucocorticoid receptor and the regulatory elements of inducible genes. Proc Natl Acad Sci USA 1986;81:3029–33.
   Google Scholar
• Umesono K, Evans RM. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989;57:1139–46.
   PubMed Web of Science ®Google Scholar
• Danielsen M, Hinck L, Ftingold GM. Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 1989;57:1131–8.
   Google Scholar
• Dahlman WK, Wright A, Gustafsson JA, Carlstedt DJ. Interac-tion of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991;266:3107–12.
   PubMedGoogle Scholar
• Picard D, Yamamoto KR. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 1987;6:3333–40.
   PubMed Web of Science ®Google Scholar
• Carlstedt-Duke J, Stromstedt PE, Persson B, Cederlund E, Gustafsson J-A, Jornvall H. Identification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other steroid hormone receptors. J Biol Chem 1988;263:6842–6.
   Google Scholar
• Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998;95:927–37.
   PubMed Web of Science ®Google Scholar
• Wurtz JM, Egner U, Heinrich N, Moras D, Mueller-Fahrnow A. Three-dimensional models of estrogen receptor ligand binding domain complexes based on related crystal structures and muta-tional and structure-activity relationship data. J Med Chem 1998;41:1803–14.
   Google Scholar
• Tanenbaum DM, Wang Y, Williams SP, Sigler PB. Crystallo-graphic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 1998;95:5998-69. 6003.
   Google Scholar
• Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in70.the oestrogen receptor. Nature 1997;389:753–8.
   Google Scholar
• Xu M, Dittmar KD, Giannoukos G, Pratt WB, Simons SS Jr. Binding of hsp90 to the glucocorticoid receptor requires a specific71.7-amino acid sequence at the amino terminus of the hormone-binding domain. J Biol Chem 1998;273:13918–24.
   Google Scholar
• Feng W, Ftibeiro RC, Wagner RL, Nguyen H, Apriletti JW,72.Fletterick RJ, et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 1998;280: 1747–9.
   Google Scholar
• Pratt WB. The role of heat shock proteins in regulating the func-73.tion, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 1993;268: 21455–8.
   Google Scholar
• Gorlich D, Vogel F, Mills AD, Hartmann E, Laskey RA. Distinct74.functions for the two importing subunits in nuclear protein im-port. Nature 1995;377: 246–8.
   Google Scholar
• Nigg EA. Nucleocytoplasmic transport: signals, mechanisms and75.regulation. Nature 1997;386:779–87.
   PubMed Web of Science ®Google Scholar
• Hsu S, Qi M, DeFranco DB. Cell cycle regulation of glucocorti-coid receptor function. EMBO J 1992;11:3457–68.
   Google Scholar
• Madan AP, DeFranco DB. Bidirectional transport of glucocorti-76.coid receptors across the nuclear envelope. Proc Natl Acad Sci USA 1993;90:3588–92.
   PubMed Web of Science ®Google Scholar
• Ogawa H, Inouye S, Tsuji Fl, Yasuda K, Umesono K. Localiza-tion, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl77.Acad Sci USA 1995;92: 11899–903.
   Google Scholar
• Sackey FNA, Haché RJG, Reich T, Kwast-Welfeld J, Lefebvre YA. Determinants of subcellular distribution of the glucocorti-78.coid receptor. Mol Endocrinol 1996;10:1191–205.
   PubMedGoogle Scholar
• Carey KL, Richards SA, Lounsbury KM, Macara IG. Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the Ran/TC4 GTPase mediates an essential function inde- pendent of nuclear protein import. J Cell Biol 1996;133:985-79.96.
   Google Scholar
• Yang J, DeFranco DB. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplas-mic trafficking. Mol Endocrinol 1996;10:3–13.
   PubMedGoogle Scholar
• Tang Y, DeFranco DB. ATP-dependent release of glucocorticoid80.receptors from the nuclear matrix. Mol Cell Biol 1996;16:1989–2001.
   PubMedGoogle Scholar
• Htun H, Barsony J, Renyi I, Gould DL, Hager GL. Proc Natl81.Acad Sci USA 1996;93: 4845–50.
   Google Scholar
• Yang J, Liu J, DeFranco DB. Subnuclear trafficking of glucocorticoid receptors in vitro: chromatin recycling and nuclear export.82.J Cell Biol 1997;137: 523–38.
   Google Scholar
• Tang Y, Ramakrishnan C, Thomas J, DeFrance DB. A role for HDJ-2/HSDJ in correcting subnuclear trafficking, transactivation, and transrepression defects of a glucocorticoid receptor zinc83.finger mutant. Mol Biol Cell 1997;8:795–809.
   Google Scholar
• Glass KC. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Mol Endocrinol 1994;15:391-407.84.
   Google Scholar
• Hörlein AJ, Näär AM, Heinzel T, Torchis J, Gloss B, Kurokawa R, et al. Ligand-independent repression by the thyroid hormone85.receptor mediated by a nuclear receptor co-repressor. Nature 1995;377: 397–404.86.
   Google Scholar
• Onate SA, Tsai SY, Tsai M-J, O'Malley BW. Sequence and char-acterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354–7.
   Google Scholar
• Katzenellenbogen JA, O'Malley BW, Katzellenbogen BS. Tripar-87.tite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific88.action of these hormones. Mol Endocrinol 1996;10: 119–31.
   Google Scholar
• Ayer DE. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol 1999;9:193–8.
   PubMedGoogle Scholar
• Berk AJ. Activation of RNA polymerase II transcription. Curr89.Opin Cell Biol 1999;11:330–5.
   PubMedGoogle Scholar
• Edwards DP. Coregulatory proteins in nuclear hormone receptor action. Vitam Horm 1999;55:165-218.90.
   Google Scholar
• Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999;9:140–7.
   Google Scholar
• Yao TP, Ku G, Zhou N, Scully R, Livingston DM. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 1996;93: 10626–31.
   Google Scholar
• Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996;383:99–103.
   PubMed Web of Science ®Google Scholar
• Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403–14.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein ElA. Nature 1996;382(6589):319–24.
   Google Scholar
• Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996;87: 953–9.
   Google Scholar
• Blanco JC, Minucci S, Lu J, Yang XJ, Walker KK, Chen H, et al. The histone acetylase P/CAF is a nuclear receptor coactivator. Genes Dev 1998;12:1638–51.
   PubMed Web of Science ®Google Scholar
• Kang KI, Meng X, Devin-Leclerc J, Bouhouche I, Chadli A, Cadepond F, et al. The molecular chaperone Hsp90 can nega-tively regulate the activity of a glucocorticosteroid-dependent promoter. Proc Natl Acad Sci USA 1999;96: 1439–44.
   Google Scholar
• Rachez C, Suldan Z, Ward J, Chang CP, Burakov D, Erdjument-Bromage H, et al. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev 1998;12: 1787–800.
   Google Scholar
• Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999;398:824–8.
   PubMed Web of Science ®Google Scholar
• Yuan CX, Ito M, Fondell JD, Fu ZY, Roeder RG. The TFtAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear re-ceptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 1998;95: 7939–44.
   Google Scholar
• Fondell JD, Guermah M, Malik S, Roeder RG. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc Natl Acad Sci USA 1999;96:1959–64.
   PubMed Web of Science ®Google Scholar
• Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 1996;15:5370–82.
   PubMed Web of Science ®Google Scholar
• Fryer CJ, Archer TK. Chromatin remodelling by the glucocorti-coid receptor requires the BRG1 complex. Nature 1998;393:88–91.
   PubMed Web of Science ®Google Scholar
• Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 1998;95:625–36.
   PubMed Web of Science ®Google Scholar
• Ghadessy FJ, Lim J, Abdullah AA, Panet-Raymond V, Choo CK, Lumbroso R, et al. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest 1999;103: 1517–25.
   Google Scholar
• Freedman LP. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 1999;97:5–8.
   PubMedGoogle Scholar
• Shao D, Lazar MA. Modulating nuclear receptor function: may the phos be with you. J Chin Invest 1999;103:1617–8.
   PubMed Web of Science ®Google Scholar
• Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. Mitogen-activated and cyclin-dependent protein kinases selec-tively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 1997;17:3947–54.
   PubMed Web of Science ®Google Scholar
• Cato ACB, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bio Essays 1996;18:371–8.
   PubMed Web of Science ®Google Scholar
• Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M, et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993;12:145–56.
   PubMed Web of Science ®Google Scholar
• McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 1998;12:45–56.
   PubMed Web of Science ®Google Scholar
• Ray A, Prefontaine KE, Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994;269: 12940–6.
   Google Scholar
• Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IlcB alpha in mediation of immu-nosuppression by glucocorticoids. Science 1995;270:283–6.
   Google Scholar
• Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-IcB ac-tivity through induction of IlcB synthesis. Science 1995;270:286–90.
   Google Scholar
• Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. IlcB alpha-independent downregulation of NF-IcB activity by glucocorticoid receptor. EMBO J 1997;16:4698–707.
   PubMed Web of Science ®Google Scholar
• Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-KB activity by glucocorticoids. Mol Endocrinol 1998;12:355–63.
   PubMed Web of Science ®Google Scholar
• Liden J, Delaunay F, Rafter I, Gustafsson J, Okret S. A new function for the C-terminal zinc finger of the glucocorticoid recep-tor. Repression of RelA transactivation. J Biol Chem 1997;272: 21467–72.
   Google Scholar
• Nissen RM, Yamamoto KR. The glucocorticoid receptor inhibits NF-KB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 2000;14: 2314–29.
   PubMed Web of Science ®Google Scholar
• Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-IcB and the glucocorticoid receptor. Proc Natl Acad Sci USA 2000;97:11893–8.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang J, Sauter NK, Pearce D. Steroid receptor hetero-dimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 1995;92:12480–4.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang J, Yu G, Liu W, Pearce D. Androgen and glucocor-ticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J Biol Chem 1997;272:14087–92.
   Google Scholar
• Makino Y, Tanaka H, Dahlman-Wright K, Gustafsson J-A, Makino I. Modulation of the glucocorticoid receptor function by metal ions. Mol Pharmacol 1996;49:612–20.
   Google Scholar
• Makino Y, Okamoto K, Yoshikawa N, Hirota K, Yodoi J, Umesono K, et al. Thioredoxin: a redox-regulating cellular cofac-tor for glucocorticoid hormone action. J Clin Invest 1996;98:2469–77.
   PubMed Web of Science ®Google Scholar
• Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, et al. Direct association with thioredoxin confers redox re-gulation of the glucocorticoid receptor function. J Biol Chem 1999;247:3182–8.
   Google Scholar
• Okamoto K, Tanaka H, Ogawa H, Makino Y, Yoshikawa N, PoeRinger L, et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999;274:10363–71.
   PubMedGoogle Scholar
• Becker PB, Gloss B, Schmid W, Strähle U, Schtz G. In vivo protein-DNA interactions in a glucocoluticoid response element require the presence of the hormone. Nature 1986;324:686–8.
   Google Scholar
• Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK. Glucocorticoid receptor-cAMP response element-binding pro-tein interaction and the response of the phosphoenol-pyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993;268: 5353–6.
   Google Scholar
• Brasier AR, Li J. Mechanisms for inducible control of angioten-sinogen gene transcription. Hypertension 1996;27:465–75.
   PubMed Web of Science ®Google Scholar
• Wurts JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 1996;3:87–94.
   PubMedGoogle Scholar
• Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389:753–8.
   PubMed Web of Science ®Google Scholar
• Williams SP, Sigler PB. Atomic structure of progesterone com-plex with its receptor. Nature 1998;393:392–6.
   PubMed Web of Science ®Google Scholar
• Gustafsson JA. Therapeutic potential of selective estrogen recep-tor modulators. Curr Opin Chem Biol 1998;2:508–11.
   PubMedGoogle Scholar
• Miura T, Ouchida R, Yoshikawa N, Okamoto K, Makino Y, Nakamura T, et al. Functional modulation of the glucocorticoid receptor and suppression of NF-KB-dependent transcription by ursodeoxycholic acid. J Biol Chem, 2001 Sep 27 (epub ahead of print), In press.
   Google Scholar